Drug Shortage Report for RABAVERT

Last updated on 2017-08-31 History
Report ID 3285
Drug Identification Number 02267667
Brand name RABAVERT
Common or Proper name Rabies vaccine
Company Name BAVARIAN NORDIC AS
Market Status MARKETED
Active Ingredient(s) RABIES VACCINE INACTIVATED
Strength(s) 2.5UNIT
Dosage form(s) POWDER FOR SOLUTION
Route of administration INTRAMUSCULAR
Packaging size 1's
ATC code J07BG
ATC description VIRAL VACCINES
Reason for shortage Demand increase for the drug.
Anticipated start date
Actual start date 2017-03-27
Estimated end date 2017-08-31
Actual end date 2017-08-30
Shortage status Resolved
Updated date 2017-08-31
Company comments Supply released July 18, 2017 with limited quantity. Supply disruptions may be seen in the private market. Product under allocation.
Health Canada comments
Tier 3 Status No
Contact Address PHILIP HEYMANS ALLE 3
HELLERUP, --
DENMARK 2900
Company contact information

Version History

Click on "Compare" below to view the full report history and compare to other versions.

Version Number Date Updated Language
v14 2017-05-03 French Compare
v13 2017-05-03 English Compare
v12 2017-04-19 French Compare
v11 2017-04-19 English Compare
v10 2017-04-05 French Compare
v9 2017-04-05 English Compare
v8 2017-03-29 French Compare
v7 2017-03-29 English Compare
v6 2017-03-29 French Compare
v5 2017-03-29 English Compare
v4 2017-03-29 English Compare
v3 2017-03-17 French Compare
v2 2017-03-17 English Compare
v1 2017-03-17 English Compare

Showing 21 to 34 of 34